News Results

There are 796,518 News Results

Sep 2, 2025
Nova Announces Proposed Private Offering of $500 Million of 0.00% Convertible Senior Notes due 2030
REHOVOT, Israel, Sept. 2, 2025 /PRNewswire/ --
Sep 2, 2025
DuPont Announces Commencement of Exchange Offers and Consent Solicitations for Senior Notes
WILMINGTON, Del., Sept. 2, 2025 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE: DD) ("DuPont") announced today the commencement of offers to exchange any and all of its outstanding senior notes...
Sep 3, 2025
Nova Announces Pricing of Upsized Private Offering of $650 Million of 0.00% Convertible Senior Notes due 2030
REHOVOT, Israel, Sept. 3, 2025 /PRNewswire/ --
Sep 9, 2025
Modeyso™ (dordaviprone) Included in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for H3 K27M-mutant Diffuse Glioma
Modeyso, the first treatment option for this ultra-rare and aggressive brain tumor, is commercially available in the United States
Sep 10, 2025
Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®
-- Mandy Moore joins Elaine Welteroth, Gaby Dalkin, Katya Echazarreta, and Shawn Johnson East to share their personal respiratory syncytial virus (RSV) stories and why they chose BEYFORTUS to help...
Sep 11, 2025
Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine
-- Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), including three oral presentations on...
Sep 16, 2025
Oracle Releases Java 25
New release delivers 18 JDK Enhancement Proposals to improve the Java language, expand its AI capabilities, and help developers accelerate productivity
Sep 17, 2025
Global System-on-Chip Design Service Market Set to Reach $5.5 Billion by 2031, Driven by Automotive and Consumer Electronics Demand | Valuates Reports
BANGALORE, India, Sept. 17, 2025 /PRNewswire/ --
Sep 21, 2025
Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy
-
Sep 22, 2025
European Commission Approves Servier's VORANIGO® (vorasidenib) as the First Targeted Therapy for Grade 2 IDH-Mutant Glioma in the EU
-- VORANIGO demonstrated significant improvement in progression-free survival with a favorable safety profile in a pivotal Phase 3 study of patients with Grade 2 IDH-mutant glioma BOSTON, Sept. 22, 2025...
79652

Pages

1

Stories of the day

Oct 3, 2025
Blighter Wins Contract from South East Asian Military for Smart and Scalable...
Oct 3, 2025
Denmark Deploys Terma’s Integrated Counter-UAS solution Across Strategic Sites
Oct 3, 2025
BAE Systems and Forterra join forces to develop autonomous Armored Multi-...
Oct 3, 2025
Oshkosh Defense Highlights U.S. Army Modernization with $89 Million PLS A2 Award